AERIE PHARMACEUTICALS
Aerie Pharmaceuticals is a biotechnology company that engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.
AERIE PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2005-01-01
Address:
Bedminster, New Jersey, United States
Country:
United States
Website Url:
http://www.aeriepharma.com
Total Employee:
251+
Status:
Active
Contact:
(908) 470-4320
Email Addresses:
[email protected]
Total Funding:
1.03 B USD
Technology used in webpage:
Apple Mobile Web Clips Icon Google Maps IPv6 Common Name Invalid ASP.NET IIS Microsoft UNPKG ASP.NET Ajax IIS 8
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Squarex
Squarex is a clinical-stage pharmaceutical company developing a drug and topical application to prevent infections.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Techfields Pharma
Techfields Pharma is a clinical stage pharmaceutical company focus on development of drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-18 | AVX Pharma | AVX Pharma acquired by Aerie Pharmaceuticals | N/A |
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - Aerie Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Post-IPO Equity - Aerie Pharmaceuticals
Clarus Ventures
Clarus Ventures investment in Series B - Aerie Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series B - Aerie Pharmaceuticals
TPG Biotech
TPG Biotech investment in Series B - Aerie Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Aerie Pharmaceuticals
Alta Partners
Alta Partners investment in Series B - Aerie Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Aerie Pharmaceuticals
TPG Biotech
TPG Biotech investment in Series A - Aerie Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.aeriepharma.com
- Host name: 104.18.30.124
- IP address: 104.18.30.124
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aerie Pharmaceuticals"
Aerie Pharmaceuticals - Wikipedia
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients with glaucoma or ocular hypertension. See details»
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (908) 470-4320 Aerie Pharmaceuticals is a biotechnology company that engages in the discovery, development, and commercialization of …See details»
Aerie Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aerie Pharmaceuticals, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Alcon - Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its ...
Aug 22, 2022 Builds on Alcon’s existing commercial expertise in the estimated $20 billion global ophthalmic pharmaceutical segment1 Adds Rocklatan ® and Rhopressa ® , and a pipeline of …See details»
Working at Aerie Pharmaceuticals - Zippia
Mar 14, 2024 aeriepharma.com. Organization Type. Public. CEO. Rajkumar Kannan. Social Media. Aerie Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, …See details»
Aerie Pharmaceuticals Company Overview, Contact Details
[email protected]: 1%. See more formats. Frequently Asked Questions Where is Aerie Pharmaceuticals 's headquarters located? Aerie Pharmaceuticals 's main headquarters …See details»
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie …See details»
Aerie Pharmaceuticals - Craft
Nov 22, 2022 Aerie Pharmaceuticals has 5 employees across 6 locations and $194.13 m in annual revenue in FY 2021. See insights on Aerie Pharmaceuticals including office locations, …See details»
Aerie Pharmaceuticals | AERI Stock Price, Company Overview
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma,See details»
Company Overview - PharmaCompass
3 Aerie IOP–Reducing Products (IP 2030+) Pipeline Activities • Rhopressa® –24-hour IOP reduction, normal tension glaucoma, etc. • Retina Program –AR-13503 andAR-1105 implants • …See details»
Aerie Pharmaceuticals Overview | SignalHire Company Profile
Phone Number: 908-470-4320: Aerie Pharmaceuticals industries Pharma: Headquarters Location: 4301 Emperor Blvd., Durham, NC, 27703 US 4301 Emperor Blvd., Durham ...See details»
Aerie Pharmaceuticals - PitchBook
Aerie Pharmaceuticals General Information Description. Operator of an ophthalmic pharmaceutical company intended to engage in eye care and treatment. The company …See details»
Aerie Pharmaceuticals - Employees, Contact info, Overview - Wiza
May 1, 2024 View info about Aerie Pharmaceuticals (aeriepharma.com). Aerie Pharmaceuticals is a company located in Durham, NC, United States. Find employees, official website, emails, …See details»
Aerie’s Competitors, Revenue, Number of Employees, Funding
Aerie’s Profile, Revenue and Employees. Aerie is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies to treat open-angle glaucoma, …See details»
Aerie Pharma - Company Profile - Tracxn
Nov 5, 2024 Aerie Pharma ranks 14th among 200 active competitors. 69 of its competitors are funded while 57 have exited. Overall, Aerie Pharma and its competitors have raised over …See details»
Aerie Pharmaceuticals, Inc. | Insights
Nov 9, 2022 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Aerie Pharmaceuticals, Inc. - Cruelty Free Investing
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
Aerie Management Team - CB Insights
Explore {Aerie's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its …
GENEVA & DURHAM, N.C.--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc. …See details»
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex …
Aerie Pharmaceuticals , an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with …See details»